Dupre Jones

• Build a shared understanding of DtP quality & stability requirements
• Map risks across DtP dispensing pathways
• Define what transparency should mean for the patient
• Identify innovation opportunities for packaging, digital tools, and logistics

As theft, tampering, counterfeiting, and cargo diversion surge across global trade lanes, freight security has become a critical pillar of pharma supply chain resilience. With high-value products, temperature-controlled shipments, and increasingly complex distribution networks, pharmaceutical companies face escalating threats and growing pressure to modernize their security strategies. In this candid, solutions-oriented discussion, senior supply chain leaders will explore how to protect high-value freight across every mile of transit. From mitigating organized cargo theft to improving visibility and chain-of-custody integrity, this panel will share practical approaches and emerging tools needed to safeguard product, brand, and patient trust.

• Implement real-time visibility and chain-of-custody tools to proactively detect and prevent shipment risks.
• Strengthen security protocols across carriers, 3PLs, and high-risk lanes through standardized SLAs and partner accountability.
• Mitigate emerging threats with risk-based freight security strategies aligned to product value, temperature requirements, and regulatory expectations.

As personalized, low-volume, high-value therapies like CAR-T and cell & gene treatments scale, both manufacturers and specialty couriers are facing unprecedented cost and capacity pressures. While these therapies are medically transformative, their logistics requirements, ultra-cold conditions, patient-specific handling, and ad hoc routing, can make transportation prohibitively expensive and operationally inefficient. This panel brings together pharma leaders and key specialty providers to unpack how both sides can rethink partnership models, cost structures, service design, and shared incentives to ensure these therapies remain viable, accessible, and sustainable.

• Align pricing models and service expectations by building transparent, long-term partnerships that reflect true volume, risk, and operational complexity
• Optimize cost drivers by exploring shared capacity, hub strategies, and alternative service designs that reduce reliance on one-off, high-cost lanes
• Collaborate earlier in therapy and network design to ensure courier capabilities, manufacturing realities, and patient needs are integrated into a scalable, affordable logistics model